Search bioRxiv⌕ Search

Biology subjects

Karan, A.

Publications and source records attributed to Karan, A..

2 recordsLinked to original sources

All-at-once RNA folding with 3D motif prediction framed by evolutionary information

Structural RNAs exhibit a vast array of recurrent short 3D elements found in loop regions involving non-Watson-Crick interactions that help arrange canonical double helices into tertiary structures. We present CaCoFold-R3D, a probabilistic grammar that predicts these RNA 3D motifs (also termed modules) jointly with RNA secondary structure over a sequence or alignment. CaCoFold-R3D uses evolutionary information present in an RNA alignment to reliably identify canonical helices (including pseudoknots) by covariation. We further introduce the R3D grammars, which also exploit helix covariation that constrains the positioning of the mostly non-covarying RNA 3D motifs. Our method runs predictions over an almost-exhaustive list of over fifty known RNA motifs (everything). Motifs can appear in any non-helical loop region (including 3-way, 4-way and higher junctions) (everywhere). All structural motifs as well as the canonical helices are arranged into one single structure predicted by one single joint probabilistic grammar (all-at-once). Our results demonstrate that CaCoFold-R3D is a valid alternative for predicting the all-residue interactions present in a RNA 3D structure. CaCoFold-R3D is fast and easily customizable for novel motif discovery and shows promising value both as a strong input for deep learning approaches to all-atom structure prediction as well as towards guiding RNA design as drug targets for therapeutic small molecules. AvailabilityThe source code can be downloaded from the website rivaslab.org, the git https://github.com/EddyRivasLab/R-scape, as well as from the supplementary materials associated to this manuscript. Supplementary informationSupplementary materials (data and code) are provided with this manuscript, and at rivaslab.org.

bioinformatics↗

Methylsulfonylmethane: A Potential Dietary Supplement targeting sphingosine kinase 1 involved in Glioblastomamultiforme

Methylsulfonylmethane (MSM) is a common dietary supplement mainly used for inflammatory disorders as well as MSM had shown anti-tumor effects on different types of cancers. However, the glioma cell line has not been tested against MSM, and we are reporting it in our study for the first time. This research used an in silico study in which sphingosine kinase 1(SphK1) is used as a therapeutic target which is associated with Glioblastoma multiforme(GBM) SphK1 is pivotal enzyme for sphingolipid metabolism whose high expression level is thought to be associated with cancer alongside other inflammatory diseases and it is a potential drug target for various types of cancer.First, in silico analysis was executed to evaluate the inhibitory effect of MSM on SphK1.Then we further observed the anti-tumor activities of MSM on the C6 glioma cell line. During in silico investigation at the initial stage, we performed molecular docking with Auto Dock Vina followed by molecular dynamics simulation at 100ns with Gromacs Software Package.MSM binds with SphK1 with a docked score of -2.1 kcal mol1. During molecular dynamics simulation complex maintain stability at 10ns but we ran simulation till 100ns to confirm the stability. We performed in depth analysis which includes post trajectory analysis like free energy landscape (FEL), principal constant analysis (PCA) with kernel density (KDE)estimation plots as well as probability distribution plots. Even molecular dynamics simulation shows stability, compactness and interaction of MSM with Sphk1, we calculated MMPBSA binding energy calculation is -13.922 +/- 19.518 kJ/mol- The viability and cellular metabolic activity of the C6 glioma in the presence of MSM showed 393.459 mM/ml of MSM reduced cell viability by 50% (CTC50) value in dose dependent manner. Further analysis like DNA fragmentation assay and Acridine orange and ethidium bromide (AO/EB) staining were carried out, which clearly depicts MSM inducing apoptosis in C6 gliomas. Based on in silico and in vitro results,for the first time we are reporting it in our study and we reach to conclusion that that MSM acts as a potential inhibitor for SphK1 as well as inhibits the growth of glioma cells and acts as a potential dietary supplement for the management of GBM which can cross blood brain barrier (BBB) and not toxic to cells even at high doze.

pharmacology and toxicology↗